Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1985 Jun;201(6):712–722. doi: 10.1097/00000658-198506000-00007

The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up.

W J Millikan Jr, W D Warren, J M Henderson, R B Smith 3rd, A A Salam, J T Galambos, M H Kutner, J H Keen
PMCID: PMC1250801  PMID: 3890781

Abstract

From 1971 to 1975, 55 patients with variceal bleeding secondary to cirrhosis were entered into a prospective randomized trial comparing distal splenorenal (selective) and H-graft interposition (nonselective) shunt. This 10-year follow-up documents that selective shunt is better (p less than 0.05) in four of the five variables monitored. Control of bleeding: selective shunt prevented variceal bleeding better than interposition shunt due to the higher (0.05 less than p less than 0.1) occlusion rate (30%) of interposition shunt. Selective shunt maintained postoperative portal perfusion better (p less than 0.01) than patent interposition shunt. Seventy-five per cent of selective shunt survivors have portal perfusion at 10 years: no patient with a patent nonselective shunt perfuses the liver. Quantitative liver function was better preserved (p less than 0.01) 10 years after selective shunt than nonselective shunt. Postoperative encephalopathy occurred in fewer (p less than 0.01) selective (27%) than nonselective (75%) shunt patients over the 10 years. Survival: in the randomized population, the improved survival in the selective shunt subgroup did not reach statistical significance. However, improved survival was confirmed in nonalcoholics. Five of eight nonalcoholics operated with selective shunt are alive at 10 years with patent shunts. No nonalcoholic, of seven total, operated with nonselective shunt survived 10 years with a patent shunt. These data show that selective shunt was superior to nonselective shunt. There was less rebleeding and encephalopathy after distal splenorenal shunt; postoperative portal perfusion and hepatic function were maintained.

Full text

PDF
712

Images in this article

719FIG. 4.
on p.719

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansley J. D., Isaacs J. W., Rikkers L. F., Kutner M. H., Nordlinger B. M., Rudman D. Quantitative tests of nitrogen metabolism in cirrhosis: relation to other manifestations of liver disease. Gastroenterology. 1978 Oct;75(4):570–579. [PubMed] [Google Scholar]
  2. Belghiti J., Grenier P., Nouel O., Nahum H., Fekete F. Long-term loss of Warren's shunt selectivity. Angiographic demonstration. Arch Surg. 1981 Sep;116(9):1121–1124. doi: 10.1001/archsurg.1981.01380210009002. [DOI] [PubMed] [Google Scholar]
  3. Campbell D. P., Parker D. E., Anagnostopoulos C. E. Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg. 1973 Dec;126(6):748–751. doi: 10.1016/s0002-9610(73)80062-5. [DOI] [PubMed] [Google Scholar]
  4. Conn H. O., Lindenmuth W. W., May C. J., Ramsby G. R. Prophylactic portacaval anastomosis. Medicine (Baltimore) 1972 Jan;51(1):27–40. doi: 10.1097/00005792-197201000-00002. [DOI] [PubMed] [Google Scholar]
  5. Conn H. O., Resnick R. H., Grace N. D., Atterbury C. E., Horst D., Groszmann R. J., Gazmuri P., Gusberg R. J., Thayer B., Berk D. Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology. 1981 Mar-Apr;1(2):151–160. doi: 10.1002/hep.1840010211. [DOI] [PubMed] [Google Scholar]
  6. Conn H. O. Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology. 1974 Nov;67(5):1065–1071. [PubMed] [Google Scholar]
  7. DOUTHWAITE A. H., TANNER N. C., LEWIS I., DESMOND A. M., JONES F. A. Gastroduodenal haemorrhage as a surgical emergency. Proc R Soc Med. 1950 Mar;43(3):145–156. [PMC free article] [PubMed] [Google Scholar]
  8. Donovan A. J., Covey P. C. Early history of the portacaval shunt in humans. Surg Gynecol Obstet. 1978 Sep;147(3):423–430. [PubMed] [Google Scholar]
  9. Drapanas T., LoCicero J., 3rd, Dowling J. B. Hemodynamics of the interposition mesocaval shunt. Ann Surg. 1975 May;181(5):523–533. doi: 10.1097/00000658-197505000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fischer J. E., Bower R. H., Atamian S., Welling R. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg. 1981 Oct;194(4):531–544. doi: 10.1097/00000658-198110000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Futagawa S., Sugiura M., Hidai K., Shima F. Emergency esophageal transection with paraesophagogastric devascularization for variceal bleeding. World J Surg. 1979 Jul 16;3(2):229–234. doi: 10.1007/BF01561282. [DOI] [PubMed] [Google Scholar]
  12. Galambos J. T., Warren W. D., Rudman D., Smith R. B., 3rd, Salam A. A. Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med. 1976 Nov 11;295(20):1089–1095. doi: 10.1056/NEJM197611112952001. [DOI] [PubMed] [Google Scholar]
  13. Groszmann R. J., Atterbury C. E. The pathophysiology of portal hypertension: a basis for classification. Semin Liver Dis. 1982 Aug;2(3):177–186. doi: 10.1055/s-2008-1040707. [DOI] [PubMed] [Google Scholar]
  14. Hassab M. A. Nonshunt operations in portal hypertension without cirrhosis. Surg Gynecol Obstet. 1970 Oct;131(4):648–654. [PubMed] [Google Scholar]
  15. Henderson J. M., Heymsfield S. B., Horowitz J., Kutner M. H. Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. Radiology. 1981 Nov;141(2):525–527. doi: 10.1148/radiology.141.2.6974875. [DOI] [PubMed] [Google Scholar]
  16. Henderson J. M., Kutner M. H., Bain R. P. First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology. 1982 Nov;83(5):1090–1096. [PubMed] [Google Scholar]
  17. Henderson J. M., Millikan W. J., Jr, Wright-Bacon L., Kutner M. H., Warren W. D. Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? Ann Surg. 1983 Sep;198(3):325–334. doi: 10.1097/00000658-198309000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jackson F. C., Perrin E. B., Felix W. R., Smith A. G. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg. 1971 Oct;174(4):672–701. doi: 10.1097/00000658-197110000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jackson F. C., Perrin E. B., Smith A. G., Dagradi A. E., Nadal H. M. A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg. 1968 Jan;115(1):22–42. doi: 10.1016/0002-9610(68)90127-x. [DOI] [PubMed] [Google Scholar]
  20. Johnston G. W., Rodgers H. W. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973 Oct;60(10):797–800. doi: 10.1002/bjs.1800601011. [DOI] [PubMed] [Google Scholar]
  21. Langer B., Rotstein L. E., Stone R. M., Taylor B. R., Patel S. C., Blendis L. M., Colapinto R. F. A prospective randomized trial of the selective distal splenorenal shunt. Surg Gynecol Obstet. 1980 Jan;150(1):45–48. [PubMed] [Google Scholar]
  22. MACBETH R. Treatment of oesophageal varices in portal hypertension by means of sclerosing injections. Br Med J. 1955 Oct 8;2(4944):877–880. doi: 10.1136/bmj.2.4944.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MOERSCH H. J. Treatment of esophageal varices by injection of a sclerosing solution. J Am Med Assoc. 1947 Nov 22;135(12):754–757. doi: 10.1001/jama.1947.02890120008004. [DOI] [PubMed] [Google Scholar]
  24. Maillard J. N., Flamant Y. M., Hay J. M., Chandler J. G. Selectivity of the distal splenorenal shunt. Surgery. 1979 Nov;86(5):663–671. [PubMed] [Google Scholar]
  25. Malt R. A., Nabseth D. C., Orloff M. J., Stipa S. Occasional notes. Portal hypertension, 1979. N Engl J Med. 1979 Sep 13;301(11):617–618. doi: 10.1056/NEJM197909133011124. [DOI] [PubMed] [Google Scholar]
  26. Malt R. B., Malt R. A. Tests and management affecting survival after portacaval and spenorenal shunts. Surg Gynecol Obstet. 1979 Aug;149(2):220–224. [PubMed] [Google Scholar]
  27. McDERMOTT W. V., Jr, ADAMS R. D. Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia. J Clin Invest. 1954 Jan;33(1):1–9. doi: 10.1172/JCI102862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mikkelsen W. P. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis. Arch Surg. 1974 Mar;108(3):302–305. doi: 10.1001/archsurg.1974.01350270036007. [DOI] [PubMed] [Google Scholar]
  29. Nabseth D. C. The distal splenorenal shunt: an enigma. Am J Surg. 1981 May;141(5):579–580. doi: 10.1016/0002-9610(81)90054-4. [DOI] [PubMed] [Google Scholar]
  30. Nordlinger B. M., Nordlinger D. F., Fulenwider J. T., Millikan W. J., Sones P. J., Kutner M., Steele R., Bain R., Warren W. D. Angiography in portal hypertension: clinical significance in surgery. Am J Surg. 1980 Jan;139(1):132–141. doi: 10.1016/0002-9610(80)90242-1. [DOI] [PubMed] [Google Scholar]
  31. PARSONS-SMITH B. G., SUMMERSKILL W. H., DAWSON A. M., SHERLOCK S. The electroencephalograph in liver disease. Lancet. 1957 Nov 2;273(7001):867–871. doi: 10.1016/s0140-6736(57)90005-3. [DOI] [PubMed] [Google Scholar]
  32. Paquet K. J., Oberhammer E. Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy. 1978 Feb;10(1):7–12. doi: 10.1055/s-0028-1098252. [DOI] [PubMed] [Google Scholar]
  33. REINHOFF W. F., Jr Ligation of the hepatic and splenic arteries in the treatment of portal hypertension with a report of six cases; preliminary report. Bull Johns Hopkins Hosp. 1951 Apr;88(4):368–375. [PubMed] [Google Scholar]
  34. Raia S., Mies S., Macedo A. L. Surgical treatment of portal hypertension in schistosomiasis. World J Surg. 1984 Oct;8(5):738–752. doi: 10.1007/BF01655771. [DOI] [PubMed] [Google Scholar]
  35. Reichle F. A., Fahmy W. F., Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg. 1979 Jan;137(1):13–21. doi: 10.1016/0002-9610(79)90004-7. [DOI] [PubMed] [Google Scholar]
  36. Reichle F. A., Owen O. E. Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts. Ann Surg. 1979 Oct;190(4):523–534. doi: 10.1097/00000658-197910000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Resnick R. H., Chalmers T. C., Ishihara A. M., Garceau A. J., Callow A. D., Schimmel E. M., O'Hara E. T. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969 Apr;70(4):675–688. doi: 10.7326/0003-4819-70-4-675. [DOI] [PubMed] [Google Scholar]
  38. Resnick R. H., Iber F. L., Ishihara A. M., Chalmers T. C., Zimmerman H. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974 Nov;67(5):843–857. [PubMed] [Google Scholar]
  39. Reynolds T. B., Donovan A. J., Mikkelsen W. P., Redeker A. G., Turrill F. L., Weiner J. M. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology. 1981 May;80(5 Pt 1):1005–1011. [PubMed] [Google Scholar]
  40. Rikkers L. F., Rudman D., Galambos J. T., Fulenwider J. T., Millikan W. J., Kutner M., Smith R. B., 3rd, Salam A. A., Sones P. J., Jr, Warren W. D. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg. 1978 Sep;188(3):271–282. doi: 10.1097/00000658-197809000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rikkers L., Jenko P., Rudman D., Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978 Sep;75(3):462–469. [PubMed] [Google Scholar]
  42. Rudman D., DiFulco T. J., Galambos J. T., Smith R. B., 3rd, Salam A. A., Warren W. D. Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest. 1973 Sep;52(9):2241–2249. doi: 10.1172/JCI107410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rueff B., Prandi D., Degos F., Sicot J., Degos J. D., Sicot C., Maillard J. N., Fauvert R., Benhamou J. P. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet. 1976 Mar 27;1(7961):655–659. doi: 10.1016/s0140-6736(76)92775-6. [DOI] [PubMed] [Google Scholar]
  44. Rypins E. B., Henderson J. M., Fulenwider J. T., Moffitt S., Galambos J. T., Warren W. D., Rudman D. A tracer method for measuring rate of urea synthesis in normal and cirrhotic subjects. Gastroenterology. 1980 Jun;78(6):1419–1424. [PubMed] [Google Scholar]
  45. Smith-Laing G., Scott J., Long R. G., Dick R., Sherlock S. Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology. 1981 May;80(5 Pt 1):1031–1036. [PubMed] [Google Scholar]
  46. Smith R. B., 3rd, Warren W. D., Salam A. A., Millikan W. J., Ansley J. D., Galambos J. T., Kutner M., Bain R. P. Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates. Ann Surg. 1980 Jul;192(1):9–17. doi: 10.1097/00000658-198007000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Starzl T. E., Francavilla A., Halgrimson C. G., Francavilla F. R., Porter K. A., Brown T. H., Putnam C. W. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet. 1973 Aug;137(2):179–199. [PMC free article] [PubMed] [Google Scholar]
  48. Stipa S., Ziparo V. Mesentericocaval shunt (MCS) with autologous jugular vein. World J Surg. 1984 Oct;8(5):702–705. doi: 10.1007/BF01655766. [DOI] [PubMed] [Google Scholar]
  49. Sugiura M., Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg. 1973 Nov;66(5):677–685. [PubMed] [Google Scholar]
  50. Sugiura M., Futagawa S. Further evaluation of the Sugiura procedure in the treatment of esophageal varices. Arch Surg. 1977 Nov;112(11):1317–1321. doi: 10.1001/archsurg.1977.01370110051005. [DOI] [PubMed] [Google Scholar]
  51. Terblanche J., Northover J. M., Bornman P., Kahn D., Barbezat G. O., Sellars S. L., Saunders S. J. A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery. 1979 Mar;85(3):239–245. [PubMed] [Google Scholar]
  52. Terblanche J., Northover J. M., Bornman P., Kahn D., Silber W., Barbezat G. O., Sellars S., Campbell J. A., Saunders S. J. A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet. 1979 Mar;148(3):323–333. [PubMed] [Google Scholar]
  53. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966;18:118–125. [PubMed] [Google Scholar]
  54. Warren W. D. Control of variceal bleeding. Reassessment of rationale. Am J Surg. 1983 Jan;145(1):8–16. doi: 10.1016/0002-9610(83)90159-9. [DOI] [PubMed] [Google Scholar]
  55. Warren W. D., Millikan W. J., Jr, Henderson J. M., Rasheed M. E., Salam A. A. Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection. Ann Surg. 1984 Jun;199(6):694–702. doi: 10.1097/00000658-198406000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Warren W. D., Millikan W. J., Jr, Henderson J. M., Wright L., Kutner M., Smith R. B., 3rd, Fulenwider J. T., Salam A. A., Galambos J. T. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg. 1982 May;195(5):530–542. doi: 10.1097/00000658-198205000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Warren W. D. Presidential address: reflections on the early development of portacaval shunts. Ann Surg. 1980 May;191(5):519–527. doi: 10.1097/00000658-198005000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Warren W. D., Rudman D., Millikan W., Galambos J. T., Salam A. A., Smith R. B., 3rd The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts. Ann Surg. 1974 Oct;180(4):573–579. doi: 10.1097/00000658-197410000-00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Warren W. D., Zeppa R., Fomon J. J. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg. 1967 Sep;166(3):437–455. doi: 10.1097/00000658-196709000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Whipple A. O. The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg. 1945 Oct;122(4):449–475. doi: 10.1097/00000658-194510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Whipple G. H., Robscheit-Robbins F. S., Hawkins W. B. ECK FISTULA LIVER SUBNORMAL IN PRODUCING HEMOGLOBIN AND PLASMA PROTEINS ON DIETS RICH IN LIVER AND IRON. J Exp Med. 1945 Feb 1;81(2):171–191. doi: 10.1084/jem.81.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Zeppa R., Hensley G. T., Levi J. U., Bergstresser P. R., Hutson D. G., Sr, Livingstone A. S., Schiff E. R., Fink P. The comparative survivals of alcoholics versus nonalcoholics after distal splenorenal shunt. Ann Surg. 1978 May;187(5):510–514. doi: 10.1097/00000658-197805000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES